Latest Videos
Michelson Philanthropies SciTalks: Progress in Vaccine Development for Infectious Diseases
Michelson Philanthropies celebrated winners of its 2021 Michelson Prizes: Next Generation Grants and Michelson Philanthropies and Science Prize for Immunology during a Keystone Symposia meeting: Progress in Vaccine Development for Infectious Diseases conference.
Dr. Rong Ma Views Personalized Cancer Research & Rock Climbing as Puzzles She Needs to Solve
Dr. Rong Ma’s research provides a pathway for using the mechanical forces involved in the human immune system to identify and predict immune responses.
ePanel Keystone Symposia: Charting the Future of Immunology and Immunotherapy
This Keystone Symposia ePanel celebrates the inaugural winners of the Michelson Philanthropies & Science Prize for Immunology, an international prize that focuses on transformative research in human immunology.
Dr. Scott Biering, Immunology Prize Finalist: Flavivirus Protein as a Target for Vaccines
Dr. Scott Biering's (University of California, Berkeley,) research reveals how a conserved flavivirus protein holds potential as a target for versatile vaccines and therapies.
Dr. Lisa Wagar, Immunology Prize Finalist: Immune Responses to Viruses and Vaccines
Dr. Lisa Wagar's (University of California, Irvine) research deciphers the immune responses to viruses and vaccines using human tonsil organoids.
Dr. Paul Bastard, Immunology Prize Recipient: Why Do People Die from COVID?
Dr. Paul Bastard of the Laboratory of Human Genetics of Infectious Diseases, Institut Imagine, INSERM & University of Paris, and The Rockefeller University, New York, received the Michelson Philanthropies & Science Grand Prize for his outstanding essay “Why do people die from COVID-19?: Autoantibodies neutralizing type I interferons increase with age.”
Dr. Camila Consiglio Explores Differences in Human Immune Responses Between the Sexes to Develop More Targeted Vaccines
Dr. Camila Consiglio, Karolinska Institutet, offers a novel approach to understanding differences in human immune responses between sexes by studying a unique cohort of people: individuals undergoing sex-re-assignment therapy.
